According to a new study, people having Parkinson's sickness can gain from deep brain stimulation in either one of two spots in the brain.
The Veterans Affairs canvassers compared two diverse targets in the brain for deep brain stimulation, the subthalamic nucleus (STN) and the globus pallidus interna (GPi), both of which influence motor role.
The process entails putting a fine wire into either of the two regions, after which an inserted battery provides a finely adjusted electrical current to motivate the brain, often leading to striking enhancement in motor function.
Researcher Frances Weaver, Director of the Center for Management of Complex Chronic Care at Hines VA Hospital in Illinois, said that majority of the neurosurgery sphere has been utilising the STN target, with only a slight confirmation that it was the top target for stimulation.
She added, "But recent reports suggest that there may be some negative consequences of STN targeting, including cognitive and psychological changes".
The report has come out in the June 3 edition of the New England Journal of Medicine.
For this research, canvassers compared the STN and GPi targets in a randomised experiment and observed patient results. In the examination, 299 patients were allocated to either STN or GPi deep brain stimulation.
Weaver's group discovered that motor function in patients enhanced equally, irrespective of which target was utilised.